Recognition of viral hemagglutinins by NKp44 but not by NKp30

Natural killer (NK) cells destroy virus‐infected and tumor cells without prior antigen stimulation. The NK cell cytotoxicity is regulated in large part by the expression of NK cell receptors that are able to bind major histocompatibility complex (MHC) class I glycoproteins. NK cells also express lysis triggering receptors specific for non‐MHC ligands, including NKp30, NKp44, NKp46 and CD16. However, the nature of their ligands, recognized on target cells, is undefined. We have recently shown that the NKp46 protein, but not the CD16 protein, recognizes the hemagglutinin (HA) of influenza virus (IV) and the hemagglutinin‐neuraminidase (HN) of Sendai virus (SV), and that the recognition of HA from IV requires the sialylation of NKp46 oligosaccharides. We have also demonstrated that binding of NKp46 to HA of IV is required for lysis of cells expressing the corresponding glycoproteins by a substantial subset of NK clones. Here we show that NKp44, but not NKp30, can also recognize the HA of both IV and SV and that the recognition of IV HA requires the sialylation of the NKp44 receptor in a similar way to that of NKp46. SV infection of 721.221 cells expressing MHC class I proteinsresulted in the abrogation of the inhibition by NK clones expressing high levels of NKp44. In addition, the binding of NKp44 to HA improves the ability of some NK clones to lyse IV infected cells.

[1]  G. Schubert,et al.  Lunar Electrical Conductivity—Reply , 1972, Nature.

[2]  J. Yewdell,et al.  Evidence for different receptor sites in mouse spleen cells for the Sendai virus hemagglutinin-neuraminidase (HN) and fusion (F) glycoproteins. , 1983, Virology.

[3]  Eric O Long,et al.  Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. , 1995, Immunity.

[4]  J. Yewdell,et al.  Monoclonal anti-hemagglutinin antibodies detect irreversible antigenic alterations that coincide with the acid activation of influenza virus A/PR/834-mediated hemolysis , 1983, Journal of virology.

[5]  J. Yewdell,et al.  Delineation of four antigenic sites on a paramyxovirus glycoprotein via which monoclonal antibodies mediate distinct antiviral activities. , 1982, Journal of immunology.

[6]  J. Skehel,et al.  Crystalline antigen from the influenza virus envelope. , 1972, Nature: New biology.

[7]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.

[8]  E. Norrby,et al.  Sendai‐Virus‐Induced Cell‐Mediated Cytotoxicity in Vitro , 1983, Scandinavian journal of immunology.

[9]  Angel Porgador,et al.  Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells , 2001, Nature.

[10]  A. Varki,et al.  Sialic acids as ligands in recognition phenomena , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  O. Mandelboim,et al.  Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules , 1996, The Journal of experimental medicine.

[12]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.

[13]  R. Biassoni,et al.  The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering. , 2000, Human immunology.

[14]  G. Herrler,et al.  Membrane cofactor protein with different types of N-glycans can serve as measles virus receptor. , 1995, Virology.

[15]  R. Biassoni,et al.  The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity , 1999, European journal of immunology.

[16]  P. Perlmann,et al.  The Role of Serologically Defined Epitopes on Mumps Virus HN‐Glycoprotein in the Induction of Virus‐Dependent Cell‐Mediated Cytotoxicity , 1985, Scandinavian journal of immunology.

[17]  M. Colonna,et al.  Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. , 1995, Science.

[18]  Jun Wu,et al.  Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells , 1998, Nature.

[19]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[20]  R. Biassoni,et al.  Molecular Cloning of NKp46: A Novel Member of the Immunoglobulin Superfamily Involved in Triggering of Natural Cytotoxicity , 1998, The Journal of experimental medicine.

[21]  L. Lanier NK cell receptors. , 1998, Annual review of immunology.

[22]  R. Biassoni,et al.  NKp44, A Triggering Receptor Involved in Tumor Cell Lysis by Activated Human Natural Killer Cells, Is a Novel Member of the Immunoglobulin Superfamily , 1999, The Journal of experimental medicine.

[23]  R. Biassoni,et al.  Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells , 1999, The Journal of experimental medicine.

[24]  R. Biassoni,et al.  Identification and Molecular Characterization of NKp 30 , a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells , 1999 .

[25]  O. Mandelboim,et al.  The human natural killer cell immune synapse. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Biassoni,et al.  NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells , 1999, European journal of immunology.

[27]  O. Mandelboim,et al.  Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  T. Mcclanahan,et al.  Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. , 1995, Journal of immunology.